Syncom Biotech Private Limited - Due diligence report

A 360° intelligence report on Syncom Biotech Private Limited: trust score, financial health, credit view, compliance, directors, growth and …

2004-04-12 Indore, Madhya Pradesh Active Unlisted Active Compliant
Share
Connect MCP
SB Syncom Biotech Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Syncom Biotech Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
81/100
Trust Score
Low Risk

Syncom Biotech Private Limited is assessed as Low Risk with a Trust Score of 81/100. Syncom Biotech Private Limited is an active private limited indian non-government company incorporated in 2004, operating in the Pharma sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 11 Oct 2026 from the latest processed filings. Syncom Biotech Private Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
81/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
81/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
60/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • No open charges - unencumbered balance sheet.
  • Elevated gearing (D/E 1.42).
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 81/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • Litigation present in 1 court forum(s).
  • 2 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
PRATIK BANKDA 01234567 Director 01/04/2018 6 yrs Approved
PRANAV BANKDA 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
06

Ownership & Group Intelligence

As per FY 2019 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
0 allotment(s) · 2 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 80
Growth signals & trust indicators
Profit expanded 2.1x year-on-year.
Asset base grew 24% - capacity expansion.
Net margin improved to 0.86.
Operating for 22+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 61% in a year.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence81/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment58/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view69/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 14 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
09 Sep 2024
Director appointed
PRANAV BANKDA (Director)
10 Nov 2021
Director ceased
PRATIK BANKDA
23 Jul 2021
Director appointed
PRATIK BANKDA (Director)
31 Dec 2020
Director ceased
UDAYAN SWAMI
30 Sep 2019
Director ceased
SUDHIR DWIVEDI
Director ceased
SANJAY CHOUHAN
29 Sep 2017
Director ceased
PRANAV BANKDA
31 Mar 2017
Share transfer (FY 2017)
5000.00000000 shares to Pratik
Share transfer (FY 2017)
5000.00000000 shares to Pranav
06 Mar 2017
Director ceased
JYOTI AJAY BANKDA
Director ceased
AJAY SHANKARLAL BANKDA
12 Apr 2004
Incorporated
Registered with Roc Gwalior
10

Key Observations

Auto-generated from the data above
Debt-to-equity stands at 38% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2019 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Light Guide Optics Private Limited U29309MP1997PTC012520 Indore, Madhya Pradesh
Unidrug Innovative Pharma Technologies Limited U85120MP1987PLC003875 Indore, Madhya Pradesh
Nexastream Infotech Private Limited U46512MP2024PTC071648 Indore, Madhya Pradesh
Febchem Engineering Private Limited U29253MP2014PTC033290 Indore, Madhya Pradesh
Cheryl Chemical Private Limited U46691MP2024PTC070816 Indore, Madhya Pradesh
Biofil Chemicals And Pharmaceuticals Limited L24233MP1985PLC002709 Indore, Madhya Pradesh
Fortune Caps & Pails Private Limited U25209MP2012PTC029116 Indore, Madhya Pradesh
Gajananaa Safe Tech Private Limited U47599MP2023PTC068849 Indore, Madhya Pradesh
Etsed Foundation U85300MP2021NPL056628 Indore, Madhya Pradesh
Valiant Electricals Pvt Ltd. U03150MP1989PTC005331 Indore, Madhya Pradesh
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Syncom Biotech Private Limited before audits and certifications: compliance score 81/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Syncom Biotech Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 70/100, margin trends, ownership structure and peer set for Syncom Biotech Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 81/100, distress signals and MSME payment-delay disclosures - know whether Syncom Biotech Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Syncom Biotech Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Syncom Biotech Private Limited an active company?

Syncom Biotech Private Limited has MCA status “Active” with a compliance score of 81/100 (Low Risk).

Is Syncom Biotech Private Limited financially healthy?

Syncom Biotech Private Limited has a Financial Health Score of 60/100 (Moderate) based on its filed financial statements.

Should I do business with Syncom Biotech Private Limited?

Its overall Trust Score is 81/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Syncom Biotech Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Syncom Biotech Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Syncom Biotech Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 81/100 (Low Risk).

Is it risky to lend to Syncom Biotech Private Limited?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.